Celyad -Model CYAD-231 -Allogeneic CAR T Candidate
FromCelyad Oncology
CYAD-231 is a dual specific CAR T candidate targeting NKG2D and an undisclosed membrane protein. The short hairpin RNA (shRNA)-based allogeneic CAR T candidate is in preclinical development.